FDA
approval
· 2023-12-22
FDA Approved: CORTROSYN — Supplemental Application (Amphastar Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for Cortrosyn (cosyntropin) from Amphastar Pharmaceuticals, Inc., authorizing changes to the approved product under …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CORTROSYN (COSYNTROPIN)